Latest Ghost Tree Capital, LLC Stock Portfolio
$361Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Ghost Tree Capital, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Ghost Tree Capital, LLC reported an equity portfolio of $361.3 Millions as of 31 Mar, 2024.
The top stock holdings of Ghost Tree Capital, LLC are AXSM, SRPT, . The fund has invested 4.6% of it's portfolio in AXSOME THERAPEUTICS INC and 4.5% of portfolio in SAREPTA THERAPEUTICS INC.
The fund managers got completely rid off AMBRX BIOPHARMA INC (AMAM), ARGENX SE (ARGX) and ASCENDIS PHARMA A/S (ASND) stocks. They significantly reduced their stock positions in KRYSTAL BIOTECH INC (KRYS), ASTRIA THERAPEUTICS INC (ATXS) and MADRIGAL PHARMACEUTICALS INC (MDGL). Ghost Tree Capital, LLC opened new stock positions in APELLIS PHARMACEUTICALS INC (APLS), BLUEPRINT MEDICINES CORP (BPMC) and VIKING THERAPEUTICS INC (VKTX). The fund showed a lot of confidence in some stocks as they added substantially to ACADIA PHARMACEUTICALS INC (ACAD), PERSPECTIVE THERAPEUTICS INC and MOONLAKE IMMUNOTHERAPEUTICS (MLTX).
The top stock holdings of Ghost Tree Capital, LLC are AXSM, SRPT, . The fund has invested 4.6% of it's portfolio in AXSOME THERAPEUTICS INC and 4.5% of portfolio in SAREPTA THERAPEUTICS INC.
The fund managers got completely rid off AMBRX BIOPHARMA INC (AMAM), ARGENX SE (ARGX) and ASCENDIS PHARMA A/S (ASND) stocks. They significantly reduced their stock positions in KRYSTAL BIOTECH INC (KRYS), ASTRIA THERAPEUTICS INC (ATXS) and MADRIGAL PHARMACEUTICALS INC (MDGL). Ghost Tree Capital, LLC opened new stock positions in APELLIS PHARMACEUTICALS INC (APLS), BLUEPRINT MEDICINES CORP (BPMC) and VIKING THERAPEUTICS INC (VKTX). The fund showed a lot of confidence in some stocks as they added substantially to ACADIA PHARMACEUTICALS INC (ACAD), PERSPECTIVE THERAPEUTICS INC and MOONLAKE IMMUNOTHERAPEUTICS (MLTX).
New Buys
| Ticker | $ Bought |
|---|---|
| APELLIS PHARMACEUTICALS INC | 7,641,400 |
| BLUEPRINT MEDICINES CORP | 6,902,110 |
| VIKING THERAPEUTICS INC | 5,986,160 |
| RHYTHM PHARMACEUTICALS INC | 5,416,250 |
| INSMED INC | 4,069,500 |
| TENAYA THERAPEUTICS INC | 4,053,250 |
| IMMUNOVANT INC | 4,038,750 |
| SPYRE THERAPEUTICS INC | 3,793,000 |
New stocks bought by Ghost Tree Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ACADIA PHARMACEUTICALS INC | 350 |
| MOONLAKE IMMUNOTHERAPEUTICS | 275 |
| PERSPECTIVE THERAPEUTICS INC | 275 |
| TG THERAPEUTICS INC | 230 |
| CRINETICS PHARMACEUTICALS IN | 207 |
| CABALETTA BIO INC | 150 |
| COGENT BIOSCIENCES INC | 130 |
| ALNYLAM PHARMACEUTICALS INC | 118 |
Additions to existing portfolio by Ghost Tree Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| KRYSTAL BIOTECH INC | -72.00 |
| ASTRIA THERAPEUTICS INC | -65.67 |
| MADRIGAL PHARMACEUTICALS INC | -56.67 |
| TAYSHA GENE THERAPIES INC | -54.76 |
| STRUCTURE THERAPEUTICS INC | -50.00 |
| EYEPOINT PHARMACEUTICALS INC | -45.45 |
| PROTAGONIST THERAPEUTICS INC | -40.00 |
| ARVINAS INC | -32.49 |
Ghost Tree Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| AMBRX BIOPHARMA INC | -6,764,000 |
| BLUEBIRD BIO INC | -641,700 |
| CYMABAY THERAPEUTICS INC | -2,125,800 |
| INHIBRX INC | -1,330,000 |
| VERONA PHARMA PLC | -596,400 |
| ASCENDIS PHARMA A/S | -2,519,000 |
| ARGENX SE | -5,706,450 |
Ghost Tree Capital, LLC got rid off the above stocks
Current Stock Holdings of Ghost Tree Capital, LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | 1.15 | 225,000 | 4,160,250 | ADDED | 350 | |
| AGLE | SPYRE THERAPEUTICS INC | 1.05 | 100,000 | 3,793,000 | NEW | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 2.48 | 60,000 | 8,967,000 | ADDED | 118 | |
| ALT | ALTIMMUNE INC | 0.70 | 250,000 | 2,545,000 | NEW | ||
| AMAM | AMBRX BIOPHARMA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ANTX | AN2 THERAPEUTICS INC | 0.20 | 219,331 | 712,826 | NEW | ||
| APLS | APELLIS PHARMACEUTICALS INC | 2.12 | 130,000 | 7,641,400 | NEW | ||
| AQST | AQUESTIVE THERAPEUTICS INC | 0.83 | 702,941 | 2,994,530 | NEW | ||
| ARGX | ARGENX SE | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ARVN | ARVINAS INC | 0.46 | 40,000 | 1,651,200 | REDUCED | -32.49 | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 0.28 | 35,000 | 1,001,000 | NEW | ||
| ASND | ASCENDIS PHARMA A/S | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ATXS | ASTRIA THERAPEUTICS INC | 0.45 | 115,000 | 1,618,620 | REDUCED | -65.67 | |
| AVTE | AEROVATE THERAPEUTICS INC | 1.84 | 225,000 | 6,653,250 | ADDED | 7.14 | |
| AXSM | AXSOME THERAPEUTICS INC | 4.64 | 210,000 | 16,758,000 | ADDED | 27.27 | |
| BBIO | BRIDGEBIO PHARMA INC | 1.50 | 175,000 | 5,411,000 | ADDED | 40.00 | |
| BLUE | BLUEBIRD BIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| BPMC | BLUEPRINT MEDICINES CORP | 1.91 | 72,761 | 6,902,110 | NEW | ||
| CABA | CABALETTA BIO INC | 1.77 | 375,000 | 6,397,500 | ADDED | 150 | |
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| COGT | COGENT BIOSCIENCES INC | 0.84 | 450,000 | 3,024,000 | ADDED | 130 | |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 0.62 | 56,941 | 2,234,360 | NEW | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | 2.59 | 200,000 | 9,362,000 | ADDED | 207 | |
| CTMX | CYTOMX THERAPEUTICS INC | 0.36 | 600,000 | 1,308,000 | NEW | ||
| CYTK | CYTOKINETICS INC | 0.39 | 20,000 | 1,402,200 | ADDED | 100 | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | 0.77 | 176,513 | 2,776,550 | REDUCED | -21.55 | |
| ELEV | ELEVATION ONCOLOGY INC | 0.36 | 250,000 | 1,282,500 | NEW | ||
| EYPT | EYEPOINT PHARMACEUTICALS INC | 0.52 | 90,000 | 1,860,300 | REDUCED | -45.45 | |
| GERN | GERON CORP | 0.73 | 800,000 | 2,640,000 | NEW | ||
| IMVT | IMMUNOVANT INC | 1.12 | 125,000 | 4,038,750 | NEW | ||
| INBX | INHIBRX INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| INSM | INSMED INC | 1.13 | 150,000 | 4,069,500 | NEW | ||
| KALV | KALVISTA PHARMACEUTICALS INC | 0.66 | 200,000 | 2,372,000 | ADDED | 53.8 | |
| KRYS | KRYSTAL BIOTECH INC | 0.69 | 14,000 | 2,491,020 | REDUCED | -72.00 | |
| LIFE | ATYR PHARMA INC | 0.32 | 600,000 | 1,170,000 | NEW | ||
| LRMR | LARIMAR THERAPEUTICS INC | 0.44 | 210,603 | 1,598,480 | NEW | ||
| MDGL | MADRIGAL PHARMACEUTICALS INC | 0.48 | 6,500 | 1,735,760 | REDUCED | -56.67 | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 4.17 | 300,000 | 15,069,000 | ADDED | 275 | |
| MRNS | MARINUS PHARMACEUTICALS INC | 0.71 | 285,000 | 2,576,400 | ADDED | 111 | |
| NTLA | INTELLIA THERAPEUTICS INC | 0.19 | 25,000 | 687,750 | NEW | ||
| NTRA | NATERA INC | 0.63 | 25,000 | 2,286,500 | REDUCED | -28.57 | |
| OLMA | OLEMA PHARMACEUTICALS INC | 0.63 | 200,000 | 2,264,000 | NEW | ||
| PCVX | VAXCYTE INC | 1.80 | 95,000 | 6,489,450 | ADDED | 35.71 | |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1.43 | 485,000 | 5,150,700 | ADDED | 25.9 | |
| PMVP | PMV PHARMACEUTICALS INC | 0.32 | 675,000 | 1,147,500 | REDUCED | -6.9 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | 0.60 | 75,000 | 2,169,750 | REDUCED | -40.00 | |
| QURE | UNIQURE NV | 0.24 | 165,000 | 858,000 | UNCHANGED | 0.00 | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 0.26 | 20,000 | 933,800 | NEW | ||
| REPL | REPLIMUNE GROUP INC | 1.47 | 650,000 | 5,310,500 | ADDED | 62.5 | |
| RGNX | REGENXBIO INC | 0.70 | 120,000 | 2,528,400 | NEW | ||
| ROIV | ROIVANT SCIENCES LTD | 3.79 | 1,300,000 | 13,702,000 | ADDED | 116 | |
| RVNC | REVANCE THERAPEUTICS INC | 0.61 | 450,000 | 2,214,000 | ADDED | 20.00 | |
| RYTM | RHYTHM PHARMACEUTICALS INC | 1.50 | 125,000 | 5,416,250 | NEW | ||
| SLNO | SOLENO THERAPEUTICS INC | 2.37 | 200,000 | 8,560,000 | ADDED | 77.96 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.99 | 150,000 | 3,570,000 | NEW | ||
| SRPT | SAREPTA THERAPEUTICS INC | 4.48 | 125,000 | 16,182,500 | ADDED | 25.00 | |
| SVRA | SAVARA INC | 2.20 | 1,600,000 | 7,968,000 | ADDED | 113 | |
| TARS | TARSUS PHARMACEUTICALS INC | 3.02 | 300,000 | 10,905,000 | UNCHANGED | 0.00 | |
| TGTX | TG THERAPEUTICS INC | 3.47 | 825,000 | 12,548,200 | ADDED | 230 | |
| TNYA | TENAYA THERAPEUTICS INC | 1.12 | 775,000 | 4,053,250 | NEW | ||
| TSHA | TAYSHA GENE THERAPIES INC | 0.76 | 950,000 | 2,726,500 | REDUCED | -54.76 | |
| VKTX | VIKING THERAPEUTICS INC | 1.66 | 73,002 | 5,986,160 | NEW | ||
| VRDN | VIRIDIAN THERAPEUTICS INC | 3.03 | 625,000 | 10,943,800 | ADDED | 108 | |
| VRNA | VERONA PHARMA PLC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| BIOHAVEN LTD | 4.31 | 285,000 | 15,586,600 | ADDED | 3.64 | ||
| PERSPECTIVE THERAPEUTICS INC | 1.98 | 6,000,000 | 7,140,000 | ADDED | 275 | ||
| ENGENE HOLDINGS INC | 0.94 | 200,000 | 3,390,000 | NEW | |||
| CG ONCOLOGY INC | 0.91 | 75,000 | 3,292,500 | NEW | |||
| STRUCTURE THERAPEUTICS INC | 0.89 | 75,000 | 3,214,500 | REDUCED | -50.00 | ||
| HELIX ACQUISITION CORP II | 0.86 | 300,000 | 3,120,000 | NEW | |||
| NEUROGENE INC | 0.35 | 25,000 | 1,272,500 | NEW | |||
| SAGIMET BIOSCIENCES INC | 0.34 | 225,000 | 1,219,500 | NEW |